GENITEC PHARMA TEST CYP 250
GENITEC PHARMA TEST CYP 250(250MG/ML TESTOSTERONE CYPIONATE=10ML)
Active-Life: 15-16 days
Drug Class: Androgenic/Anabolic Steroid (For injection)
Average Reported Dosage: Men 200-1000mg weekly
Acne: Yes, common
Water Retention: Yes, high
High Blood Pressure: Yes, due to water/electrolyte retention
Liver Toxic: Low, except in absurd dosages
Aromatization: Yes, high
DHT conversion: Yes, high
Decreases HPTA Function: Yes, severely
Pretty much all that was written about TESTOSTERONE ENANTHATE also applies to TESTOSTERONE CYPIONATE. A slight distinction was made in that they
each provided a notable different half- and active-life period. For this reason, CYPIONATE injections were reduced to every 8th day by some reported users. Dosages of 200-1000mg weekly were common, but most users experienced excellent results with 200-600mg weekly. Both testosterone preparations stacked well with any other AAS and added a distinct androgenic effect. This meant improved regenerative qualities and greater training intensity with a correlating significant increase in weight-load capacity. For those who wished to use testosterone but were highly sensitive to gyno and water
retention, TESTOSTERONE PROPIONATE was commonly reported to be the better
choice. Oddly enough, a few of those polled reported more sensitively due to Propionate's fast action. Interesting paradox, huh? The issue was simply a matter of dosage/administration protocols. Since PROPIONATE remained active for about 3 days a weekly administration protocol allowed circulatory clearing of the drug. It should be
noted that both TESTOSTERONE ENANTHATE and CYPIONATE were said to be
more anabolic and less androgenic then SUSPENSION or PROPIONATE. This is pure imagination. The truth is that suspension actually is a faster acting testosterone and contains more total testosterone per 100mg dosage than any esterfied testosterone.
testosterone cypionate which is the oil-soluble 17 (beta)-cyclopentylpropionate ester of the androgenic hormone testosterone.
Endogenous androgens are responsible for normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include growth and maturation of the prostate, seminal vesicles, penis, and scrotum; development of male hair distribution, such as beard, pubic, chest, and axillary hair; laryngeal enlargement, vocal cord thickening, and alterations in body musculature and fat distribution. Drugs in this class also cause retention of nitrogen, sodium, potassium, and phosphorous, and decreased urinary excretion of calcium. Androgens have been reported to increase protein anabolism and decrease protein catabolism. Nitrogen balance is improved only when there is sufficient intake of calories and protein.
Androgens are responsible for the growth spurt of adolescence and for eventual termination of linear growth, brought about by fusion of the epiphyseal growth centers. In children, exogenous androgens accelerate linear growth rates, but may cause disproportionate advancement in bone maturation. Use over long periods may result in fusion of the epiphyseal growth centers and termination of the growth process. Androgens have been reported to stimulate production of red blood cells by enhancing production of erythropoietic stimulation factor.